HHS Overhauls Grants Policy, Consolidates Agencies, and Boosts Pediatric Health Initiatives

This week, the Department of Health and Human Services unveiled a sweeping revision to its Grants Policy Statement, described by insiders as one of the department’s most significant administrative shake-ups in years. Effective October 1st, these changes will affect every HHS grant awarded moving forward, including a requirement that any cumulative budget change exceeding 10 percent of the total grant now demands prior agency approval, replacing the previous 25 percent threshold. There’s also new, required language for civil rights assurances, explicitly tying all grantees to Title IX standards—provisions aimed at strengthening protections across education and health programs, as detailed by Feldesman Tucker policy advisors. Another highlight is a new mandate for no-cost grant extensions: grantees must now submit requests at least 10 days before their budget period wraps up, aligning with HHS’s focus on transparency and fiscal discipline. Landlords leasing space to HHS-funded programs are also required to provide consent letters for improvements; a change that reflects long-standing but now formalized practice. HHS now holds the explicit right to end grants at its own discretion, with no appeals process—a move expected to provide the agency more agility but raising concerns among nonprofits and community groups. In program news, HHS announced the launch of a new “Autism Action Plan,” taking important steps to address rising rates of autism spectrum disorder in children. The FDA is now authorizing state Medicaid coverage of leucovorin for children with cerebral folate deficiency associated with autism, and the NIH will fund new clinical trials to deepen our understanding of these treatments. HHS is also rolling out a public safety campaign on acetaminophen use during pregnancy, encouraging informed judgment by clinicians with new labeling and research partnerships. Some advocates say these steps represent long-awaited momentum in pediatric health. Meanwhile, the department is also implementing broader organizational changes, consolidating several agencies into a new Administration for a Healthy America. The Centers for Disease Control and Prevention will now focus primarily on infectious diseases, with chronic disease and prevention programs shifting to state responsibility. These changes follow President Trump’s Cost Efficiency Initiative, which aims to streamline HHS operations and reduce its workforce by up to 20,000 employees. Robert F. Kennedy Jr., the new Secretary, asserted last week that this reorganization will cut redundancy—pointing to the department’s more than 100 separate communications offices as an example of inefficiency. Adding more urgency, HHS is doubling its funding for the Childhood Cancer Data Initiative, emphasizing artificial intelligence research to improve pediatric cancer outcomes. President Trump recently announced a major push for tech-driven innovation, directing current HHS efforts to integrate AI into disease su This content was created in partnership and with the help of Artificial Intelligence AI.